MedPath

Efficacy of Modified Constraint-Induced Movement Therapy on the Upper Limb Function of Sub-acute Stroke Patients in Peshawar Pakistan

Not Applicable
Not yet recruiting
Conditions
Stroke
Registration Number
NCT05570461
Lead Sponsor
NCS University System
Brief Summary

This RCT will also help the clinicians to provide the best treatment to their patients for better outcomes.

The objective of the study is to determine the efficacy of Modified Constraint-induced movement therapy on the Upper Limb function of Sub-acute stroke patients in Peshawar Pakistan.

Alternative Hypothesis: There will be a difference in the means of Modified Constraint-induced movement therapyand traditional physical therapy on the upper limb function of subacute stroke patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
46
Inclusion Criteria
    1. Age 30 to 60 years
    1. Both female & male will be included.
    1. Cognitive and lingual ability to communicate with the research staff.
    1. A minimum of 10 degrees of active finger extension and 20 degrees of active wrist extension(16).
    1. A history of a single stroke resulting in a hemiparesis
Exclusion Criteria
    1. Recurrent stroke during the training period.
    1. Neurological or orthopedic disorders prohibiting the use of the paretic arm.
    1. Patients who doesn't show willingness to participate in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Wolf Motor function test4weeks

Use mainly for post-stroke patients with impaired upper limb motor ability. The purpose of this test is to enumerate upper limb motor ability through a series of functional tasks. The WMFT is an instrument with high internal consistency, interrater reliability and test-retest reliability. The quality of movement during the task is measured by functional ability scale, a 6-point ordinal scale, where 0 = does not attempt with the impaired arm and 5 = arm movement appear to be normal.

Higher the value higher will be the normal function.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.